clinical trial · NCT06821061
A Study to Learn About How the Flu and COVID-19 Vaccines Act in Healthy People
InfluenzaCOVID-19 (Coronavirus Disease 2019)Investigational Influenza VaccineInvestigational COVID-19 VaccineInvestigational Influenza and COVID-19 Combination VaccineLicensed Influenza Vaccine 1Licensed Influenza Vaccine 2Licensed Influenza Vaccine 3Licensed COVID-19 Vaccine
brief summary
The purpose of this study is to learn about how the flu and COVID vaccines act when given alone or when mixed together. This study is seeking healthy participants aged 18 or older. All participants in this study will receive only 1 shot to their arm, either a flu or COVID vaccine, alone or mixed. Participants will take part in this study for about 6 months, and participants will need to visit the clinical study site at least 4 times.
started
Feb 10, 2025
primary completion
Dec 17, 2025
completion
Dec 17, 2025
last updated
Jan 26, 2026
official title
A PHASE 1/2 RANDOMIZED, DOUBLE-BLINDED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF MODIFIED RNA VACCINE CANDIDATES AGAINST INFLUENZA AND COVID-19 IN HEALTHY INDIVIDUALS
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol